_id
69105705ccc777a4e85d5661
Ticker
CUBT
Name
Curative Biotechnology Inc
Exchange
NYSE MKT
Address
3801 PGA Blvd, Palm Beach Gardens, FL, United States, 33410
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://curativebiotech.com
Description
Curative Biotechnology, Inc., a biopharmaceutical company, focuses on identifying, in licensing, and developing therapeutic drug candidates for rare disease indications. It develops Metformin Reformulation to treat intermediate dry macular degeneration and geographic atrophy; IMT504, a novel immunotherapy to treat late-stage rabies; and CUBT906, a fully humanized CD56 monoclonal antibody carrying a cytotoxic drug conjugate directly to the tumor site to kill the tumor by inhibiting tumor growth and migration of the tumor. The company has a licensing and co-development agreement with Mid-Atlantic BioTherapeutics, Inc. to develop IMT504 to treat late-stage rabies and COVID-19 vaccine. Curative Biotechnology, Inc. was founded in 1995 and is headquartered in Palm Beach Gardens, Florida.
Last Close
0.0045
Volume
2638868
Current Price
0.004325
Change
-0.0001
Last Updated
2026-01-02T12:12:10.280Z
Image
-
Ipo Date
2017-09-20T00:00:00.000Z
Market Cap
5648920
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-03-31
Revenue
-
Cost Of Revenue
21928
Gross Profit
-21928
Operating Expenses
260610
Operating Income
-283000
Interest Expense
199595
Pretax Income
-482000
Net Income
-482000
Eps
-0.0005171135622150914
Dividends Per Share
-
Shares Outstanding
1046096400
Income Tax Expense
-
EBITDA
-260000
Operating Margin
-
Total Other Income Expense Net
-199000
Cash
218263
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
355624
Property Plant Equipment
2050
Total Assets
2285228
Payables
4172656
Short Term Debt
3106820
Long Term Debt
-
Total Liabilities
7279476
Equity
-4994248
Bs_currency_symbol
-
Depreciation
21928
Change In Working Capital
178544
Cash From Operations
-185272
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
384000
Net Change In Cash
198729
Cf_currency_symbol
-
PE
-
PB
-0.8071924992511385
ROE
9.651102628463784
ROA
-21.091987320302394
FCF
-185272
Fcf Percent
-
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
0.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
3.5
Net Net Investing Score
0.5
Quality Investing Score
0.5
Value Investing Score
1
Quarters > 0 > quarter
2025-03-31
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
21928
Quarters > 0 > income Statement > gross Profit
-21928
Quarters > 0 > income Statement > operating Expenses
260610
Quarters > 0 > income Statement > operating Income
-283000
Quarters > 0 > income Statement > interest Expense
199595
Quarters > 0 > income Statement > pretax Income
-482000
Quarters > 0 > income Statement > net Income
-482000
Quarters > 0 > income Statement > eps
-0.0005171135622150914
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
932097000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-260000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-199000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
218263
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
355624
Quarters > 0 > balance Sheet > property Plant Equipment
2050
Quarters > 0 > balance Sheet > total Assets
2285228
Quarters > 0 > balance Sheet > payables
4172656
Quarters > 0 > balance Sheet > short Term Debt
3106820
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
7279476
Quarters > 0 > balance Sheet > equity
-4994248
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-481585
Quarters > 0 > cash Flow > depreciation
21928
Quarters > 0 > cash Flow > change In Working Capital
178544
Quarters > 0 > cash Flow > cash From Operations
-185272
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
384000
Quarters > 0 > cash Flow > net Change In Cash
198729
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.0005171135622150914
Quarters > 0 > ratios > PB
-0.8071924992511385
Quarters > 0 > ratios > ROE
9.651102628463784
Quarters > 0 > ratios > ROA
-21.091987320302394
Quarters > 0 > ratios > FCF
-185272
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
21929
Quarters > 1 > income Statement > gross Profit
-21929
Quarters > 1 > income Statement > operating Expenses
650695
Quarters > 1 > income Statement > operating Income
-673000
Quarters > 1 > income Statement > interest Expense
231232
Quarters > 1 > income Statement > pretax Income
-903000
Quarters > 1 > income Statement > net Income
-903000
Quarters > 1 > income Statement > eps
-0.0009823086537802566
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
919263000
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-649000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-230000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
19534
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
211888
Quarters > 1 > balance Sheet > property Plant Equipment
2392
Quarters > 1 > balance Sheet > total Assets
2163420
Quarters > 1 > balance Sheet > payables
4126588
Quarters > 1 > balance Sheet > short Term Debt
1368859
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
7076031
Quarters > 1 > balance Sheet > equity
-4912611
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-902598
Quarters > 1 > cash Flow > depreciation
21929
Quarters > 1 > cash Flow > change In Working Capital
-65619
Quarters > 1 > cash Flow > cash From Operations
-164807
Quarters > 1 > cash Flow > capital Expenditures
3
Quarters > 1 > cash Flow > cash From Investing
15000
Quarters > 1 > cash Flow > cash From Financing
132501
Quarters > 1 > cash Flow > net Change In Cash
-17306
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.0009823086537802566
Quarters > 1 > ratios > PB
-0.8093074080158188
Quarters > 1 > ratios > ROE
18.381264056934285
Quarters > 1 > ratios > ROA
-41.739468064453504
Quarters > 1 > ratios > FCF
-164810
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
37
Quarters > 2 > quarter
2024-09-30
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
21928
Quarters > 2 > income Statement > gross Profit
-21928
Quarters > 2 > income Statement > operating Expenses
438651
Quarters > 2 > income Statement > operating Income
-461000
Quarters > 2 > income Statement > interest Expense
421486
Quarters > 2 > income Statement > pretax Income
-882000
Quarters > 2 > income Statement > net Income
-882000
Quarters > 2 > income Statement > eps
-0.0009764597907807582
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
903263000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-439000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-421000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
36840
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
317851
Quarters > 2 > balance Sheet > property Plant Equipment
2734
Quarters > 2 > balance Sheet > total Assets
2291312
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
2794654
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
6781372
Quarters > 2 > balance Sheet > equity
-4490060
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-882065
Quarters > 2 > cash Flow > depreciation
21928
Quarters > 2 > cash Flow > change In Working Capital
149440
Quarters > 2 > cash Flow > cash From Operations
-530261
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
262750
Quarters > 2 > cash Flow > net Change In Cash
-267511
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.0009764597907807582
Quarters > 2 > ratios > PB
-0.8700579669313995
Quarters > 2 > ratios > ROE
19.643390066057023
Quarters > 2 > ratios > ROA
-38.493230079535216
Quarters > 2 > ratios > FCF
-530261
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2024-06-30
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
21928
Quarters > 3 > income Statement > gross Profit
-21928
Quarters > 3 > income Statement > operating Expenses
549288
Quarters > 3 > income Statement > operating Income
-571000
Quarters > 3 > income Statement > interest Expense
127037
Quarters > 3 > income Statement > pretax Income
-698000
Quarters > 3 > income Statement > net Income
-698000
Quarters > 3 > income Statement > eps
-0.0007727538933843188
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
903263000
Quarters > 3 > income Statement > income Tax Expense
2
Quarters > 3 > income Statement > EBITDA
-549000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-127000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
304351
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
10000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
432644
Quarters > 3 > balance Sheet > property Plant Equipment
3076
Quarters > 3 > balance Sheet > total Assets
2428033
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
2467096
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
6195028
Quarters > 3 > balance Sheet > equity
-3766995
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-697743
Quarters > 3 > cash Flow > depreciation
21928
Quarters > 3 > cash Flow > change In Working Capital
236000
Quarters > 3 > cash Flow > cash From Operations
-235921
Quarters > 3 > cash Flow > capital Expenditures
1
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
421669
Quarters > 3 > cash Flow > net Change In Cash
185748
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.0007727538933843188
Quarters > 3 > ratios > PB
-1.0370633555393622
Quarters > 3 > ratios > ROE
18.529358281601116
Quarters > 3 > ratios > ROA
-28.747549971520158
Quarters > 3 > ratios > FCF
-235922
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
38
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
92213
Annuals > 0 > income Statement > gross Profit
-92213
Annuals > 0 > income Statement > operating Expenses
2349000
Annuals > 0 > income Statement > operating Income
-2441000
Annuals > 0 > income Statement > interest Expense
1125000
Annuals > 0 > income Statement > pretax Income
-3565000
Annuals > 0 > income Statement > net Income
-3565000
Annuals > 0 > income Statement > eps
-0.003926600654249871
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
907910000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-2348000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-1124000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
19534
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
211888
Annuals > 0 > balance Sheet > property Plant Equipment
2392
Annuals > 0 > balance Sheet > total Assets
2163420
Annuals > 0 > balance Sheet > payables
4126588
Annuals > 0 > balance Sheet > short Term Debt
1368859
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
7076031
Annuals > 0 > balance Sheet > equity
-4912611
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-3564890
Annuals > 0 > cash Flow > depreciation
92213
Annuals > 0 > cash Flow > change In Working Capital
828370
Annuals > 0 > cash Flow > cash From Operations
-1022740
Annuals > 0 > cash Flow > capital Expenditures
1
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
985875
Annuals > 0 > cash Flow > net Change In Cash
-36866
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.003926600654249871
Annuals > 0 > ratios > PB
-0.9979853890324312
Annuals > 0 > ratios > ROE
72.568334842714
Annuals > 0 > ratios > ROA
-164.78538610163537
Annuals > 0 > ratios > FCF
-1022741
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
38
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
-
Annuals > 1 > income Statement > cost Of Revenue
97515
Annuals > 1 > income Statement > gross Profit
-97515
Annuals > 1 > income Statement > operating Expenses
1835000
Annuals > 1 > income Statement > operating Income
-1933000
Annuals > 1 > income Statement > interest Expense
1357000
Annuals > 1 > income Statement > pretax Income
-3957000
Annuals > 1 > income Statement > net Income
-3957000
Annuals > 1 > income Statement > eps
-0.005975888039313702
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
662161000
Annuals > 1 > income Statement > income Tax Expense
-5
Annuals > 1 > income Statement > EBITDA
-2502000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-2024000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
56400
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
115625
Annuals > 1 > balance Sheet > inventories
-115625
Annuals > 1 > balance Sheet > total Current Assets
604451
Annuals > 1 > balance Sheet > property Plant Equipment
5809
Annuals > 1 > balance Sheet > total Assets
2603196
Annuals > 1 > balance Sheet > payables
3487440
Annuals > 1 > balance Sheet > short Term Debt
2258381
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
5745821
Annuals > 1 > balance Sheet > equity
-3142625
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-3956813
Annuals > 1 > cash Flow > depreciation
90015
Annuals > 1 > cash Flow > change In Working Capital
-46551
Annuals > 1 > cash Flow > cash From Operations
-486585
Annuals > 1 > cash Flow > capital Expenditures
14041
Annuals > 1 > cash Flow > cash From Investing
-14041
Annuals > 1 > cash Flow > cash From Financing
498358
Annuals > 1 > cash Flow > net Change In Cash
-2268
Annuals > 1 > cash Flow > currency_symbol
-
Annuals > 1 > ratios > PE
-0.005975888039313702
Annuals > 1 > ratios > PB
-1.1377970327353726
Annuals > 1 > ratios > ROE
125.91384590907282
Annuals > 1 > ratios > ROA
-152.00545790635817
Annuals > 1 > ratios > FCF
-500626
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
39
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
7955
Annuals > 2 > income Statement > gross Profit
-7955
Annuals > 2 > income Statement > operating Expenses
4436000
Annuals > 2 > income Statement > operating Income
-4467000
Annuals > 2 > income Statement > interest Expense
918487
Annuals > 2 > income Statement > pretax Income
-5380415
Annuals > 2 > income Statement > net Income
-5380000
Annuals > 2 > income Statement > eps
-0.009405429975000438
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
572010000
Annuals > 2 > income Statement > income Tax Expense
1175000
Annuals > 2 > income Statement > EBITDA
-4362000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-913573
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
58668
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
68668
Annuals > 2 > balance Sheet > property Plant Equipment
6264
Annuals > 2 > balance Sheet > total Assets
2089191
Annuals > 2 > balance Sheet > payables
3433702
Annuals > 2 > balance Sheet > short Term Debt
1124896
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
22618928
Annuals > 2 > balance Sheet > equity
-2538346
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-5380000
Annuals > 2 > cash Flow > depreciation
853531
Annuals > 2 > cash Flow > change In Working Capital
2803674
Annuals > 2 > cash Flow > cash From Operations
-1535573
Annuals > 2 > cash Flow > capital Expenditures
76905
Annuals > 2 > cash Flow > cash From Investing
-76905
Annuals > 2 > cash Flow > cash From Financing
1000883
Annuals > 2 > cash Flow > net Change In Cash
-611595
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.009405429975000438
Annuals > 2 > ratios > PB
-1.2168766590527849
Annuals > 2 > ratios > ROE
211.94904083210088
Annuals > 2 > ratios > ROA
-257.51594756056295
Annuals > 2 > ratios > FCF
-1612478
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
6744
Annuals > 3 > income Statement > gross Profit
-6744
Annuals > 3 > income Statement > operating Expenses
4997000
Annuals > 3 > income Statement > operating Income
-5014000
Annuals > 3 > income Statement > interest Expense
176672
Annuals > 3 > income Statement > pretax Income
-5340000
Annuals > 3 > income Statement > net Income
-5340000
Annuals > 3 > income Statement > eps
-0.01654275092936803
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
322800000
Annuals > 3 > income Statement > income Tax Expense
176672
Annuals > 3 > income Statement > EBITDA
-5157000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-326000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
670263
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
25000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
753905
Annuals > 3 > balance Sheet > property Plant Equipment
6720
Annuals > 3 > balance Sheet > total Assets
2412150
Annuals > 3 > balance Sheet > payables
726904
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
18773892
Annuals > 3 > balance Sheet > equity
1681815
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-5340354
Annuals > 3 > cash Flow > depreciation
6744
Annuals > 3 > cash Flow > change In Working Capital
549026
Annuals > 3 > cash Flow > cash From Operations
-1604035
Annuals > 3 > cash Flow > capital Expenditures
21334
Annuals > 3 > cash Flow > cash From Investing
-21334
Annuals > 3 > cash Flow > cash From Financing
2135025
Annuals > 3 > cash Flow > net Change In Cash
509656
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.01654275092936803
Annuals > 3 > ratios > PB
1.0364516905842796
Annuals > 3 > ratios > ROE
-317.51411421589177
Annuals > 3 > ratios > ROA
-221.3792674584914
Annuals > 3 > ratios > FCF
-1625369
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
16
Valuation > metrics > PE
-0.0005171135622150914
Valuation > metrics > PB
-0.8071924992511385
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
9.651102628463784
Profitability > metrics > ROA
-135.53640924122107
Profitability > final Score
34
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-1.417871189158045
Risk > final Score
24
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.048852966889375
Liquidity > metrics > Quick Ratio
0.048852966889375
Liquidity > final Score
12
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
52
Prev Profitabilities > 1
54
Prev Profitabilities > 2
52
Prev Risks > 0
18
Prev Risks > 1
26
Prev Risks > 2
12
Prev Liquidities > 0
12
Prev Liquidities > 1
16
Prev Liquidities > 2
19
Updated At
2026-01-20T21:40:37.684Z
Earnings History > 0 > period
2023-03-31
Earnings History > 0 > report Date
2023-05-19
Earnings History > 0 > date
2023-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.0017
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2022-12-31
Earnings History > 1 > report Date
2022-12-31
Earnings History > 1 > date
2022-12-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.0027
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2022-09-30
Earnings History > 2 > report Date
2022-09-30
Earnings History > 2 > date
2022-09-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0025
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-06-30
Earnings History > 3 > report Date
2022-06-30
Earnings History > 3 > date
2022-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.0023
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-03-31
Earnings History > 4 > report Date
2022-03-31
Earnings History > 4 > date
2022-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.0024
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2021-12-31
Earnings History > 5 > report Date
2021-12-31
Earnings History > 5 > date
2021-12-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.0016
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-09-30
Earnings History > 6 > report Date
2021-09-30
Earnings History > 6 > date
2021-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-0.0019
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2021-06-30
Earnings History > 7 > report Date
2021-06-30
Earnings History > 7 > date
2021-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.0008
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2021-03-31
Earnings History > 8 > report Date
2021-03-31
Earnings History > 8 > date
2021-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-0.0022
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2020-12-31
Earnings History > 9 > report Date
2021-03-09
Earnings History > 9 > date
2020-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-0.0008
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2020-09-30
Earnings History > 10 > report Date
2020-09-30
Earnings History > 10 > date
2020-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
0
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2020-06-30
Earnings History > 11 > report Date
2020-06-30
Earnings History > 11 > date
2020-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
0
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2019-12-31
Earnings History > 12 > report Date
2020-03-31
Earnings History > 12 > date
2019-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
0.0011
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0.0011
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-12-31
Earnings History > 13 > report Date
2019-03-31
Earnings History > 13 > date
2018-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
0
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2014-03-31
Earnings History > 14 > report Date
2014-03-31
Earnings History > 14 > date
2014-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-0.0002
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2013-12-31
Earnings History > 15 > report Date
2013-12-31
Earnings History > 15 > date
2013-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
-0.0001
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2013-09-30
Earnings History > 16 > report Date
2013-09-30
Earnings History > 16 > date
2013-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
0
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2013-06-30
Earnings History > 17 > report Date
2013-06-30
Earnings History > 17 > date
2013-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
-0.0001
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2013-03-31
Earnings History > 18 > report Date
2013-03-31
Earnings History > 18 > date
2013-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
-0.0001
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2012-12-31
Earnings History > 19 > report Date
2012-12-31
Earnings History > 19 > date
2012-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
-0.0003
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2012-09-30
Earnings History > 20 > report Date
2012-09-30
Earnings History > 20 > date
2012-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
-
Earnings History > 20 > eps Actual
-0.0003
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2012-06-30
Earnings History > 21 > report Date
2012-06-30
Earnings History > 21 > date
2012-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
-
Earnings History > 21 > eps Actual
-0.0004
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2012-03-31
Earnings History > 22 > report Date
2012-03-31
Earnings History > 22 > date
2012-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
-
Earnings History > 22 > eps Actual
-0.0005
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2011-12-31
Earnings History > 23 > report Date
2011-12-31
Earnings History > 23 > date
2011-12-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
-
Earnings History > 23 > eps Actual
-0.0016
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2011-09-30
Earnings History > 24 > report Date
2011-12-31
Earnings History > 24 > date
2011-09-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
-
Earnings History > 24 > eps Actual
-0.0017
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2011-06-30
Earnings History > 25 > report Date
2011-06-30
Earnings History > 25 > date
2011-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
-
Earnings History > 25 > eps Actual
-0.0005
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2011-03-31
Earnings History > 26 > report Date
2011-03-31
Earnings History > 26 > date
2011-03-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
-
Earnings History > 26 > eps Actual
-0.0014
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2010-12-31
Earnings History > 27 > report Date
2010-12-31
Earnings History > 27 > date
2010-12-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
-
Earnings History > 27 > eps Actual
0.0005
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2010-09-30
Earnings History > 28 > report Date
2010-09-30
Earnings History > 28 > date
2010-09-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
-
Earnings History > 28 > eps Actual
-0.0106
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2010-06-30
Earnings History > 29 > report Date
2010-06-30
Earnings History > 29 > date
2010-06-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
-
Earnings History > 29 > eps Actual
-0.0201
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2010-03-31
Earnings History > 30 > report Date
2010-03-31
Earnings History > 30 > date
2010-03-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
-
Earnings History > 30 > eps Actual
-0.0416
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Curative Biotechnology, Inc., a biopharmaceutical company, focuses on identifying, in licensing, and developing therapeutic drug candidates for rare disease indications. It develops Metformin Reformulation to treat intermediate dry macular degeneration and geographic atrophy; IMT504, a novel immunotherapy to treat late-stage rabies; and CUBT906, a fully humanized CD56 monoclonal antibody carrying a cytotoxic drug conjugate directly to the tumor site to kill the tumor by inhibiting tumor growth and migration of the tumor. The company has a licensing and co-development agreement with Mid-Atlantic BioTherapeutics, Inc. to develop IMT504 to treat late-stage rabies and COVID-19 vaccine. Curative Biotechnology, Inc. was founded in 1995 and is headquartered in Palm Beach Gardens, Florida.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-03-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Curative Biotechnology Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2023-03-31
EPS Actual
-0.0017
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-03-31)
(Last Updated 2025-03-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-03-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-03-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.